Publications by authors named "Z-H Zhu"

Approximately 20% of patients with shingles develop postherpetic neuralgia (PHN). We investigated the role of gut microbiota in shingle- and PHN-related pain. Patients with shingles or PHN exhibited significant alterations in their gut microbiota with microbial markers predicting PHN development among patients with shingles.

View Article and Find Full Text PDF

Rationale And Objectives: To comprehensively assess the feasibility of low-dose computed tomography (LDCT) using deep learning image reconstruction (DLIR) for evaluating pulmonary subsolid nodules, which are challenging due to their susceptibility to noise.

Materials And Methods: Patients undergoing both standard-dose CT (SDCT) and LDCT between March and June 2023 were prospectively enrolled. LDCT images were reconstructed with high-strength DLIR (DLIR-H), medium-strength DLIR (DLIR-M), adaptive statistical iterative reconstruction-V level 50% (ASIR-V-50%), and filtered back projection (FBP); SDCT with FBP as the reference standard.

View Article and Find Full Text PDF

In tomato, sugar content is highly correlated with consumer preferences, with most consumers preferring sweeter fruit. However, the sugar content of commercial varieties is generally low, as it is inversely correlated with fruit size, and growers prioritize yield over flavour quality. Here we identified two genes, tomato (Solanum lycopersicum) calcium-dependent protein kinase 27 (SlCDPK27; also known as SlCPK27) and its paralogue SlCDPK26, that control fruit sugar content.

View Article and Find Full Text PDF
Article Synopsis
  • SARS-CoV-2 infects host cells by using its spike protein's receptor binding domain (RBD) to bind to the ACE2 receptor, which is crucial for the virus's entry into cells.
  • The ACE2 receptor consists of several domains, with the peptidase domain (PD) being essential for its function as a viral receptor; however, the receptor needs to be close to the cell membrane for effective infection.
  • Researchers found that engineered proteins targeting the RBD can influence whether cells are susceptible or resistant to the virus, indicating potential paths for antiviral therapies.
View Article and Find Full Text PDF
Article Synopsis
  • The EMPA-KIDNEY trial examined the effects of empagliflozin, an SGLT2 inhibitor, on patients with chronic kidney disease at risk for progression, assessing outcomes during and after the trial.
  • A total of 6609 patients were randomized, with 4891 participating in a follow-up period after the trial where they were observed for an additional 2 years, without trial medication but allowed to use other SGLT2 inhibitors.
  • Results showed that fewer primary outcome events (like kidney disease progression or cardiovascular death) occurred in the empagliflozin group (26.2%) compared to the placebo group (30.3%), suggesting lasting benefits of the drug even after the trial ended. *
View Article and Find Full Text PDF

Purpose: To investigate the clinical outcomes after arthroscopic chondral nail fixation for acetabular cartilage delamination (ACD) in patients with femoroacetabular impingement syndrome (FAIS), as well as the presentation of ACD on magnetic resonance imaging (MRI), at follow-up.

Methods: A retrospective review was performed between March 2021 and March 2022 at our institute. Patients undergoing primary hip arthroscopy for FAIS in whom ACD was diagnosed intraoperatively were included.

View Article and Find Full Text PDF

Purpose: To evaluate the surveillance value of circulating tumor DNA (ctDNA) for detecting distant metastasis and indicating systemic therapeutic efficacy in conjunctival melanoma (CoM).

Design: Retrospective, observational case series.

Methods: From July 2021 to June 2023, 30 CoM patients in our center underwent plasma ctDNA assessment, out of which 12 individuals presented with distant metastases.

View Article and Find Full Text PDF

The prevalence of many chronic noncommunicable diseases has been steadily rising over the past six decades. During this time, over 350,000 new chemical substances have been introduced to the lives of humans. In recent years, the epithelial barrier theory came to light explaining the growing prevalence and exacerbations of these diseases worldwide.

View Article and Find Full Text PDF
Article Synopsis
  • Influenza and COVID-19 are two major respiratory diseases that have led to significant health challenges worldwide, prompting the need for an effective combined vaccine to avoid multiple doses.
  • Researchers created a chimeric protein subunit vaccine combining parts of the influenza virus and the SARS-CoV-2 virus, demonstrating effectiveness in mouse models against various strains.
  • An mRNA vaccine candidate was developed from this chimeric antigen, showing strong immune responses and complete protection in mice against both influenza and different strains of SARS-CoV-2, with the potential for easy adaptation to new variants.
View Article and Find Full Text PDF

Among their many unique biological features, bats are increasingly recognized as a key reservoir of many emerging viruses that cause massive morbidity and mortality in humans. Bats are capable of harboring many of these deadly viruses without any apparent signs of pathology, in a mechanism known as viral disease tolerance. However, the immunological mechanisms behind viral tolerance remain poorly understood.

View Article and Find Full Text PDF
Article Synopsis
  • The KCNQ1+KCNE1 potassium channel is vital for heart stress adaptation, where β-adrenergic stimulation enhances its activity via phosphorylation, essential for managing increased heart rates.
  • Variants in the KCNQ1 gene can lead to long-QT syndrome type 1 (LQT1), with some mutations making patients more susceptible to serious heart risks, but the details of how phosphorylation affects channel function and cAMP sensitivity are still unclear.
  • Research using techniques like patch clamp and induced pluripotent stem cells revealed key molecular features in LQT1 variants and identified a small molecule, ML277, that can restore function in high-risk mutations by targeting the phosphorylation axis of the channel.
View Article and Find Full Text PDF

Not all MET exon 14 skipping (METex14) NSCLC patients benefited from MET inhibitors. We hypothesized an inter-tumoral heterogeneity in METex14 NSCLC. Investigations at genomic and transcriptomic level were conducted in METex14 NSCLC samples from stage I-III and recurrent/metastatic patients as discovery and validation cohort.

View Article and Find Full Text PDF

Background And Purpose: Patients with autosomal dominant polycystic kidney disease (ADPKD) develop cysts in the kidneys, liver, spleen, pancreas, prostate, and arachnoid spaces. In addition, spinal meningeal diverticula have been reported. To determine whether spinal meningeal diverticula are associated with ADPKD, we compared their prevalence in subjects with ADPKD with a control cohort without ADPKD.

View Article and Find Full Text PDF

Rationale And Objectives: This study explored the intratumor heterogeneity (ITH) of esophageal squamous cell carcinoma (ESCC) using computed tomography (CT) and investigated the value of CT-based ITH in predicting the response to immune checkpoint inhibitor (ICI) plus chemotherapy in patients with ESCC.

Materials And Methods: This retrospective study included 416 patients with ESCC who received ICI plus chemotherapy at two independent hospitals between January 2019 and July 2022. Multiparametric CT features were extracted from ESCC lesions and screened using hierarchical clustering and dimensionality reduction algorithms.

View Article and Find Full Text PDF

Recent single-arm studies involving neoadjuvant camrelizumab, a PD-1 inhibitor, plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (LA-ESCC) have shown promising results. This multicenter, randomized, open-label phase 3 trial aimed to further assess the efficacy and safety of neoadjuvant camrelizumab plus chemotherapy followed by adjuvant camrelizumab, compared to neoadjuvant chemotherapy alone. A total of 391 patients with resectable thoracic LA-ESCC (T1b-3N1-3M0 or T3N0M0) were stratified by clinical stage (I/II, III or IVA) and randomized in a 1:1:1 ratio to undergo two cycles of neoadjuvant therapy.

View Article and Find Full Text PDF
Article Synopsis
  • This study evaluated the effectiveness and safety of combining bevacizumab with carboplatin and paclitaxel (CP) as a first-line treatment for stage III/IV ovarian cancer in Chinese patients after surgery.
  • Results showed that patients receiving bevacizumab + CP had a median progression-free survival (PFS) of 22.6 months, significantly longer than the 12.3 months for those on placebo + CP.
  • The safety profile indicated that treatment-related severe side effects were more common in the bevacizumab group (94%) compared to the placebo group (68%), but the drug's overall safety was consistent with previous findings.
View Article and Find Full Text PDF

Background: Exercise-induced physiological cardiac growth regulators may protect the heart from ischemia/reperfusion (I/R) injury. Homeobox-containing 1 (Hmbox1), a homeobox family member, has been identified as a putative transcriptional repressor and is downregulated in the exercised heart. However, its roles in exercise-induced physiological cardiac growth and its potential protective effects against cardiac I/R injury remain largely unexplored.

View Article and Find Full Text PDF

Background: 12,13-dihydroxy-9Z-octadecenoic acid (12,13-diHOME) has shown potential in protecting against heart disease, but its relationship with atrial fibrillation (AF) remains unknown.

Methods: Coronary sinus (CS) and femoral vein blood samplings were synchronously collected from AF and non-AF subjects (paroxysmal supraventricular tachycardia or idiopathic premature ventricular complexes) who underwent catheter ablation. First, untargeted metabolomic profiling was performed in a discovery cohort (including 12 AF and 12 non-AF subjects) to identify the most promising CS or femoral vein metabolite.

View Article and Find Full Text PDF
Article Synopsis
  • - Bietti crystalline corneoretinal dystrophy is a genetic retinal disease linked to CYP4V2 mutations, causing blindness, and currently has no treatment.
  • - A clinical trial (NCT04722107) tested a gene therapy called rAAV2/8-hCYP4V2 in 12 participants, showing mostly mild side effects, and achieved improvements in vision for 77.8% of patients by day 180.
  • - The trial results indicated a positive safety profile and significant visual acuity improvements, supporting further research and development of this gene therapy (ZVS101e).
View Article and Find Full Text PDF

CRISPR-Cas systems and IS200/IS605 transposon-associated TnpBs have been utilized for the development of genome editing technologies. Using bioinformatics analysis and biochemical experiments, here we present a new family of RNA-guided DNA endonucleases. Our bioinformatics analysis initially identifies the stable co-occurrence of conserved RAGATH-18-derived RNAs (reRNAs) and their upstream IS607 TnpBs with an average length of 390 amino acids.

View Article and Find Full Text PDF

Interleukin 12 (IL-12) is a potent immunostimulatory cytokine mainly produced by antigen-presenting cells (e.g., dendritic cells, macrophages) and plays an important role in innate and adaptive immunity against cancers.

View Article and Find Full Text PDF

Background: Adipose-derived stem cells (ADSCs) are closely associated with the survival rate of transplanted fat in breast reconstruction after breast cancer surgery. Nevertheless, the intrinsic mechanisms regulating ADSCs adipogenic differentiation remain ambiguous. The aim of our study was to explore the relevant genes and pathways to elucidate the potential mechanisms of adipogenic differentiation in ADSCs.

View Article and Find Full Text PDF

Rationale And Objectives: To evaluate the image quality of low-dose CT colonography (CTC) using deep learning-based reconstruction (DLR) compared to iterative reconstruction (IR).

Materials And Methods: Adults included in the study were divided into four groups according to body mass index (BMI). Routine-dose (RD: 120 kVp) CTC images were reconstructed with IR (RD-IR); low-dose (LD: 100kVp) images were reconstructed with IR (LD-IR) and DLR (LD-DLR).

View Article and Find Full Text PDF

Background: Oral antiviral drugs with improved antiviral potency and safety are needed to address current challenges in clinical practice for treatment of COVID-19, including the risks of rebound, drug-drug interactions, and emerging resistance.

Methods: Olgotrelvir (STI-1558) is designed as a next-generation antiviral targeting the SARS-CoV-2 main protease (M), an essential enzyme for SARS-CoV-2 replication, and human cathepsin L (CTSL), a key enzyme for SARS-CoV-2 entry into host cells.

Findings: Olgotrelvir is a highly bioavailable oral prodrug that is converted in plasma to its active form, AC1115.

View Article and Find Full Text PDF

The chemokine receptor CXCR4 has become an attractive therapeutic target for HIV-1 infection, hematopoietic stem cell mobilization, and cancer metastasis. A wide variety of synthetic antagonists of CXCR4 have been developed and studied for a growing list of clinical applications. To compare the biological effects of different antagonists on CXCR4 functions and their common and/or distinctive molecular interactions with the receptor, we conducted head-to-head comparative cell-based biological and mutational analyses of the interactions with CXCR4 of eleven reported antagonists, including HC4319, DV3, DV1, DV1 dimer, V1, vMIP-II, CVX15, LY2510924, IT1t, AMD3100, and AMD11070 that were representative of different structural classes of D-peptides, L-peptide, natural chemokine, cyclic peptides, and small molecules.

View Article and Find Full Text PDF